JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M000569200 on March 15, 2000

J. Biol. Chem., Vol. 275, Issue 22, 16857-16864, June 2, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/22/16857    most recent
M000569200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kremer, L.
Right arrow Articles by Besra, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kremer, L.
Right arrow Articles by Besra, G. S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Thiolactomycin and Related Analogues as Novel Anti-mycobacterial Agents Targeting KasA and KasB Condensing Enzymes in Mycobacterium tuberculosis*

Laurent Kremerab, James D. Douglascd, Alain R. Baularde, Caroline Morehousea, Mark R. Guyac, David Allandf, Lynn G. Dovera, Jeremy H. Lakeyg, William R. Jacobs Jr.h, Patrick J. Brennani, David E. Minnikinc, and Gurdyal S. Besraaj

From the Departments of a Microbiology and Immunology and c Chemistry, g School of Biochemistry and Genetics, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH England, e INSERM U447, Institut Pasteur de Lille, 59019 Lille, France, the f Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center, Bronx, New York 10467, the h Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, New York, 10461, and the i Department of Microbiology, Colorado State University, Fort Collins, Colorado 80523-1677

Prevention efforts and control of tuberculosis are seriously hampered by the appearance of multidrug-resistant strains of Mycobacterium tuberculosis, dictating new approaches to the treatment of the disease. Thiolactomycin (TLM) is a unique thiolactone that has been shown to exhibit anti-mycobacterial activity by specifically inhibiting fatty acid and mycolic acid biosynthesis. In this study, we present evidence that TLM targets two beta -ketoacyl-acyl-carrier protein synthases, KasA and KasB, consistent with the fact that both enzymes belong to the fatty-acid synthase type II system involved in fatty acid and mycolic acid biosynthesis. Overexpression of KasA, KasB, and KasAB in Mycobacterium bovis BCG increased in vivo and in vitro resistance against TLM. In addition, a multidrug-resistant clinical isolate was also found to be highly sensitive to TLM, indicating promise in counteracting multidrug-resistant strains of M. tuberculosis. The design and synthesis of several TLM derivatives have led to compounds more potent both in vitro against fatty acid and mycolic acid biosynthesis and in vivo against M. tuberculosis. Finally, a three-dimensional structural model of KasA has also been generated to improve understanding of the catalytic site of mycobacterial Kas proteins and to provide a more rational approach to the design of new drugs.

* This work was supported by the Medical Research Council (United Kingdom); by NIAID, National Institutes of Health Grants AI-18357, AI-33706, and AI-43268; and by Cooperative Agreement AI-38087 from the National Cooperative Drug Discovery Groups for the Treatment of Opportunistic Infections, NIAID, National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

b Supported through a Heiser Trust postdoctoral fellowship.

d Holder of a United Kingdom Engineering and Physical Research Council Quota studentship.

j A Lister Institute-Jenner Research Fellow. To whom correspondence should be addressed. Tel.: 0191-222-5412; Fax: 0191-222-7736; E-mail: g.s.besra@newcastle.ac.uk.

Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 MicrobiologyHome page
V. Bhowruth, A. K. Brown, and G. S. Besra
Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636
Microbiology, July 1, 2008; 154(7): 1866 - 1875.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. Gratraud, N. Surolia, G. S. Besra, A. Surolia, and L. Kremer
Antimycobacterial Activity and Mechanism of Action of NAS-91
Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1162 - 1166.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
A. K. Brown, A. Bhatt, A. Singh, E. Saparia, A. F. Evans, and G. S. Besra
Identification of the dehydratase component of the mycobacterial mycolic acid-synthesizing fatty acid synthase-II complex
Microbiology, December 1, 2007; 153(12): 4166 - 4173.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
A. K. Brown, A. Papaemmanouil, V. Bhowruth, A. Bhatt, L. G. Dover, and G. S. Besra
Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II
Microbiology, October 1, 2007; 153(10): 3314 - 3322.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. E. Boyne, T. J. Sullivan, C. W. amEnde, H. Lu, V. Gruppo, D. Heaslip, A. G. Amin, D. Chatterjee, A. Lenaerts, P. J. Tonge, et al.
Targeting Fatty Acid Biosynthesis for the Development of Novel Chemotherapeutics against Mycobacterium tuberculosis: Evaluation of A-Ring-Modified Diphenyl Ethers as High-Affinity InhA Inhibitors
Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3562 - 3567.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
T. Parish, G. Roberts, F. Laval, M. Schaeffer, M. Daffe, and K. Duncan
Functional Complementation of the Essential Gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but Not Escherichia coli fabG
J. Bacteriol., May 15, 2007; 189(10): 3721 - 3728.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Bhatt, N. Fujiwara, K. Bhatt, S. S. Gurcha, L. Kremer, B. Chen, J. Chan, S. A. Porcelli, K. Kobayashi, G. S. Besra, et al.
Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice
PNAS, March 20, 2007; 104(12): 5157 - 5162.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-M. Zhang, S. W. White, and C. O. Rock
Inhibiting Bacterial Fatty Acid Synthesis
J. Biol. Chem., June 30, 2006; 281(26): 17541 - 17544.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
R. Mathew, R. Mukherjee, R. Balachandar, and D. Chatterji
Deletion of the rpoZ gene, encoding the {omega} subunit of RNA polymerase, results in pleiotropic surface-related phenotypes in Mycobacterium smegmatis
Microbiology, June 1, 2006; 152(6): 1741 - 1750.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Lack, E. Homberger-Zizzari, G. Folkers, L. Scapozza, and R. Perozzo
Recombinant Expression and Biochemical Characterization of the Unique Elongating beta-Ketoacyl-Acyl Carrier Protein Synthase Involved in Fatty Acid Biosynthesis of Plasmodium falciparum Using Natural and Artificial Substrates
J. Biol. Chem., April 7, 2006; 281(14): 9538 - 9546.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. Young, H. Jayasuriya, J. G. Ondeyka, K. Herath, C. Zhang, S. Kodali, A. Galgoci, R. Painter, V. Brown-Driver, R. Yamamoto, et al.
Discovery of FabH/FabF Inhibitors from Natural Products
Antimicrob. Agents Chemother., February 1, 2006; 50(2): 519 - 526.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
A. Bhatt, L. Kremer, A. Z. Dai, J. C. Sacchettini, and W. R. Jacobs Jr
Conditional Depletion of KasA, a Key Enzyme of Mycolic Acid Biosynthesis, Leads to Mycobacterial Cell Lysis
J. Bacteriol., November 15, 2005; 187(22): 7596 - 7606.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. K. Brown, S. Sridharan, L. Kremer, S. Lindenberg, L. G. Dover, J. C. Sacchettini, and G. S. Besra
Probing the Mechanism of the Mycobacterium tuberculosis {beta}-Ketoacyl-Acyl Carrier Protein Synthase III mtFabH: FACTORS INFLUENCING CATALYSIS AND SUBSTRATE SPECIFICITY
J. Biol. Chem., September 16, 2005; 280(37): 32539 - 32547.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
A. Burguiere, P. G. Hitchen, L. G. Dover, A. Dell, and G. S. Besra
Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole
Microbiology, June 1, 2005; 151(6): 2087 - 2095.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Zhang, A. K. Joshi, J. Hofmann, E. Schweizer, and S. Smith
Cloning, Expression, and Characterization of the Human Mitochondrial {beta}-Ketoacyl Synthase: COMPLEMENTATION OF THE YEAST CEM1 KNOCK-OUT STRAIN
J. Biol. Chem., April 1, 2005; 280(13): 12422 - 12429.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
J. Starck, G. Kallenius, B.-I. Marklund, D. I. Andersson, and T. Akerlund
Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions
Microbiology, November 1, 2004; 150(11): 3821 - 3829.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
X. He, A. M. Reeve, U. R. Desai, G. E. Kellogg, and K. A. Reynolds
1,2-Dithiole-3-Ones as Potent Inhibitors of the Bacterial 3-Ketoacyl Acyl Carrier Protein Synthase III (FabH)
Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3093 - 3102.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
O. Zimhony, C. Vilcheze, and W. R. Jacobs Jr.
Characterization of Mycobacterium smegmatis Expressing the Mycobacterium tuberculosis Fatty Acid Synthase I (fas1) Gene
J. Bacteriol., July 1, 2004; 186(13): 4051 - 4055.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Ducasse-Cabanot, M. Cohen-Gonsaud, H. Marrakchi, M. Nguyen, D. Zerbib, J. Bernadou, M. Daffe, G. Labesse, and A. Quemard
In Vitro Inhibition of the Mycobacterium tuberculosis {beta}-Ketoacyl-Acyl Carrier Protein Reductase MabA by Isoniazid
Antimicrob. Agents Chemother., January 1, 2004; 48(1): 242 - 249.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. C. Betts, A. McLaren, M. G. Lennon, F. M. Kelly, P. T. Lukey, S. J. Blakemore, and K. Duncan
Signature Gene Expression Profiles Discriminate between Isoniazid-, Thiolactomycin-, and Triclosan-Treated Mycobacterium tuberculosis
Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2903 - 2913.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Kremer, L. G. Dover, H. R. Morbidoni, C. Vilcheze, W. N. Maughan, A. Baulard, S.-C. Tu, N. Honore, V. Deretic, J. C. Sacchettini, et al.
Inhibition of InhA Activity, but Not KasA Activity, Induces Formation of a KasA-containing Complex in Mycobacteria
J. Biol. Chem., May 30, 2003; 278(23): 20547 - 20554.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. V. Ramaswamy, R. Reich, S.-J. Dou, L. Jasperse, X. Pan, A. Wanger, T. Quitugua, and E. A. Graviss
Single Nucleotide Polymorphisms in Genes Associated with Isoniazid Resistance in Mycobacterium tuberculosis
Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1241 - 1250.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. F. Waller, S. A. Ralph, M. B. Reed, V. Su, J. D. Douglas, D. E. Minnikin, A. F. Cowman, G. S. Besra, and G. I. McFadden
A Type II Pathway for Fatty Acid Biosynthesis Presents Drug Targets in Plasmodium falciparum
Antimicrob. Agents Chemother., January 1, 2003; 47(1): 297 - 301.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
J. D. Douglas, S. J. Senior, C. Morehouse, B. Phetsukiri, I. B. Campbell, G. S. Besra, and D. E. Minnikin
Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activity
Microbiology, October 1, 2002; 148(10): 3101 - 3109.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M.D. Iseman
Tuberculosis therapy: past, present and future
Eur. Respir. J., July 1, 2002; 20(36_suppl): 87S - 94s.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Jackowski, Y.-M. Zhang, A. C. Price, S. W. White, and C. O. Rock
A Missense Mutation in the fabB ({beta}-Ketoacyl-Acyl Carrier Protein Synthase I) Gene Confers Thiolactomycin Resistance to Escherichia coli
Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1246 - 1252.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
H. Marrakchi, S. Ducasse, G. Labesse, H. Montrozier, E. Margeat, L. Emorine, X. Charpentier, M. Daffe, and A. Quemard
MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II
Microbiology, April 1, 2002; 148(4): 951 - 960.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. L. Schaeffer, G. Agnihotri, C. Volker, H. Kallender, P. J. Brennan, and J. T. Lonsdale
Purification and Biochemical Characterization of the Mycobacterium tuberculosisbeta -Ketoacyl-acyl Carrier Protein Synthases KasA and KasB
J. Biol. Chem., December 7, 2001; 276(50): 47029 - 47037.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
G. E. Schujman, K.-H. Choi, S. Altabe, C. O. Rock, and D. de Mendoza
Response of Bacillus subtilis to Cerulenin and Acquisition of Resistance
J. Bacteriol., May 15, 2001; 183(10): 3032 - 3040.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
N. M. Parrish, T. Houston, P. B. Jones, C. Townsend, and J. D. Dick
In Vitro Activity of a Novel Antimycobacterial Compound, N-Octanesulfonylacetamide, and Its Effects on Lipid and Mycolic Acid Synthesis
Antimicrob. Agents Chemother., April 1, 2001; 45(4): 1143 - 1150.
[Abstract] [Full Text]

Home page
 J. Bacteriol.Home page
C. Vilchèze, H. R. Morbidoni, T. R. Weisbrod, H. Iwamoto, M. Kuo, J. C. Sacchettini, and W. R. Jacobs Jr.
Inactivation of the inhA-Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis
J. Bacteriol., July 15, 2000; 182(14): 4059 - 4067.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
K.-H. Choi, L. Kremer, G. S. Besra, and C. O. Rock
Identification and Substrate Specificity of beta -Ketoacyl (Acyl Carrier Protein) Synthase III (mtFabH) from Mycobacterium tuberculosis
J. Biol. Chem., September 1, 2000; 275(36): 28201 - 28207.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. C. Price, K.-H. Choi, R. J. Heath, Z. Li, S. W. White, and C. O. Rock
Inhibition of beta -Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin. STRUCTURE AND MECHANISM
J. Biol. Chem., February 23, 2001; 276(9): 6551 - 6559.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. N. Scarsdale, G. Kazanina, X. He, K. A. Reynolds, and H. T. Wright
Crystal Structure of the Mycobacterium tuberculosisbeta -Ketoacyl-Acyl Carrier Protein Synthase III
J. Biol. Chem., June 1, 2001; 276(23): 20516 - 20522.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Kremer, L. G. Dover, C. Morehouse, P. Hitchin, M. Everett, H. R. Morris, A. Dell, P. J. Brennan, M. R. McNeil, C. Flaherty, et al.
Galactan Biosynthesis in Mycobacterium tuberculosis. IDENTIFICATION OF A BIFUNCTIONAL UDP-GALACTOFURANOSYLTRANSFERASE
J. Biol. Chem., July 6, 2001; 276(28): 26430 - 26440.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Kremer, K. M. Nampoothiri, S. Lesjean, L. G. Dover, S. Graham, J. Betts, P. J. Brennan, D. E. Minnikin, C. Locht, and G. S. Besra
Biochemical Characterization of Acyl Carrier Protein (AcpM) and Malonyl-CoA:AcpM Transacylase (mtFabD), Two Major Components of Mycobacterium tuberculosis Fatty Acid Synthase II
J. Biol. Chem., July 20, 2001; 276(30): 27967 - 27974.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.